Literature DB >> 26402299

The Slippery Slope of Broadening Treatment Eligibility and Weak End Points: Defending the Oligo in Oligometastatic Non-Small-Cell Lung Cancer.

Howard Jack West1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26402299     DOI: 10.1001/jamaoncol.2015.2966

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis.

Authors:  Dianhe Li; Xiaoxia Zhu; Haofei Wang; Min Qiu; Na Li
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.